GlassScriptPhysician profile
John M Menezes
NPI 1891773404
$3,129.96
in general payments reported to CMS, 2019-2025
13 companies · $68.74 in 2025
The $68.74 reported for 2025 was less than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
See the full distribution for Plastic Surgery Within the Head and Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2021: $311 · 2022: $423 · 2023: $343 · 2024: $1,502 · 2025: $68.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $1,262.72 | 2019-2024 | |
| Abbvie INC. | $472.36 | 2023-2024 | |
| Tela Bio, INC. | $372.28 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $345.84 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Integra Lifesciences Corporation | $140.63 | 2019-2023 | Integra, Surgimend, Omnigraft |
| Mentor Worldwide LLC | $126.19 | 2019-2022 | |
| Goode Surgical INC | $124.84 | 2022 | |
| Allergan, INC. | $116.73 | 2019 | |
| Sientra, INC. | $71.74 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $33.23 | 2019 | |
| Southern Implants North America INC | $25.69 | 2023 | |
| Acera Surgical, INC. | $19.90 | 2022 | |
| Stryker Corporation | $17.81 | 2023 | Core |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Menezes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.